Skip to Content
Merck
All Photos(3)

Key Documents

View All Documentation

P38706

Sigma-Aldrich

Phthalazine

98%

Synonym(s):

β-Phenodiazine, 2,3-Benzodiazine, 2,3-Diazanaphthalene, Benzo[d]pyridazine

Sign Into View Organizational & Contract Pricing
All Photos(3)

About This Item

Empirical Formula (Hill Notation):
C8H6N2
CAS Number:
253-52-1
Molecular Weight:
130.15
EC Number:
205-963-2
MDL number:
MFCD00006908
UNSPSC Code:
12352100
PubChem Substance ID:
24898461
NACRES:
NA.22

Assay

98%

form

crystals

bp

189 °C/29 mmHg (lit.)

mp

89-92 °C (lit.)

storage temp.

2-8°C

SMILES string

c1ccc2cnncc2c1

InChI

1S/C8H6N2/c1-2-4-8-6-10-9-5-7(8)3-1/h1-6H

InChI key

LFSXCDWNBUNEEM-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Pictograms

Health hazard
GHS08

Signal Word

Warning

Hazard Statements

H341,H412

Hazard Classifications

Aquatic Chronic 3 - Muta. 2

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Manuel Sánchez-Moreno et al.
The Journal of antimicrobial chemotherapy, 67(2), 387-397 (2011-12-01)
To evaluate the in vitro leishmanicidal activity of imidazole-based (1-4) and pyrazole-based (5-6) benzo[g]phthalazine derivatives against Leishmania infantum and Leishmania braziliensis. The in vitro activity of compounds 1-6 was assayed on extracellular promastigote and axenic amastigote forms, and on intracellular
Michał Achmatowicz et al.
The Journal of organic chemistry, 74(2), 795-809 (2008-12-18)
p38 MAP kinase inhibitors have attracted considerable interest as potential agents for the treatment of inflammatory diseases. Herein, we describe a concise and efficient synthesis of inhibitor 1 that is based on a phthalazine scaffold. Highlights of our approach include
Mehdi Rashidi et al.
Inorganic chemistry, 49(18), 8435-8443 (2010-08-18)
The reaction of phthalazine with the binuclear organoplatinum complexes [Me(2)Pt(μ-SMe(2))(μ-dppm)PtR(2)], R = Me, Ph, 4-tolyl or R(2) = (CH(2))(4), dppm = bis(diphenylphosphino)methane, gives the corresponding complexes [Me(2)Pt(μ-phthalazine)(μ-dppm)PtR(2)] by displacement of the bridging dimethylsulfide ligand. The structures of [Me(2)Pt(μ-SMe(2))(μ-dppm)PtMe(2)] and [Me(2)Pt(μ-phthalazine)(μ-dppm)PtMe(2)]
Design and synthesis of selective and potent orally active S1P5 agonists.
Henri Mattes et al.
ChemMedChem, 5(10), 1693-1696 (2010-09-04)
Fadi M Awadallah et al.
European journal of medicinal chemistry, 52, 14-21 (2012-03-24)
New phthalazine-based vasodilators were synthesized through the chloroacylation of the starting compound 1-hydrazinophthalazine 4 to give the two key intermediates 5 and 7. These intermediates were used to alkylate various cyclic amines to furnish the final compounds 6a-h and 8a-h.
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service